Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib
Gavric, Ana Ursula, Ocvirk, Janja, Mekjavic, Polona Jaki
Malignant gliomas: old and new systemic treatment approaches
Mesti, Tanja, Ocvirk, Janja
The five-year KRAS, NRAS and BRAF analysis results and treatment patterns in daily clinical practice in Slovenia in 1st line treatment of metastatic colorectal (mCRC) patients with RAS wild-type tumour (wtRAS) – a real- life data report 2013–2018
Mesti, Tanja, Rebersek, Martina, Ocvirk, Janja
A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a metaanalysis
Ocvirk, Janja, Heeger, Steffen, McCloud, Philip, Hofheinz, Ralf-Dieter
Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma
Moltara, Maja Ebert, Novakovic, Srdjan, Boc, Marko, Bucic, Marina, Rebersek, Martina, Zadnik, Vesna, Ocvirk, Janja
Adverse events during immunotherapy in Slovenian patients with metastatic melanoma reveal a positive correlation with better treatment outcomes
Mesti, Tanja, Ceplak Mencin, Vid, Mileva Boshkoska, Biljana, Ocvirk, Janja
Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
Mesti, Tanja, Ebert Moltara, Maja, Boc, Marko, Rebersek, Martina, Ocvirk, Janja
Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients
Rebersek, Martina, Mesti, Tanja, Boc, Marko, Ocvirk, Janja
Cisplatin-induced non-convulsive posterior reversible encephalopathy syndrome in a 41-year-old woman with metastatic malignant melanoma
Ocvirk, Janja, Boc, Marko, Rebersek, Martina, Ros, Tanja
Paratesticular adenocarcinoma: unusual presentation of metastasis of pancreatic cancer
Ocvirk, Janja, Šeruga, Boštjan
Cetuximab in preoperative treatment of rectal cancer - term outcome of the XERT trial
Velenik, Vaneja, Ocvirk, Janja, Oblak, Irena, Anderluh, Franc
Efficacy of first-line systemic treatment in correlation with BRAF V600E and different KRAS mutations in metastatic colorectal cancer - a single institution retrospective analysis
Rebersek, Martina, Boc, Marko, Cerkovnik, Petra, Benedik, Jernej, Hlebanja, Zvezdana, Volk, Neva, Novakovic, Srdjan, Ocvirk, Janja